Skip to main content
. 2011 Dec 14;1(1):3. doi: 10.1007/s13554-011-0009-3

Figure 2.

Figure 2.

Initialization of SCIG therapy in previously untreated primary immunodeficiency (PI) patients. (A) PI study design. Dose adjustments in patients not achieving serum IgG levels of ≥5 g/L by day 12 were planned for day 15 (an additional dose of 150 mg/kg bw) and day 19 (a dose increased to 150 mg/kg). Reproduced from Borte M et al.,16 J Clin Immunol 2011; Sep 20. [Epub ahead of print] (Fig. 1), with kind permission from Springer Science+Business Media B.V. (B) Increase in serum IgG levels after five consecutive daily doses of 100 mg/kg SCIG. Mean ± SD serum levels are shown. The arrow indicates the target for primary endpoint: IgG levels >5 g/L at day 12. bw=body weight; IgG=immunoglobulin G; s.c.=subcutaneous; SCIG=subcutaneous immunoglobulin.